Trial intelligence / Profile preview

Myfortic Preload in Kidney Transplant

NCT01336296Phase 4Completed

Sponsor
University of Cincinnati
Start
Sep 2010
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of mycophenolic acid in kidney transplant rejection, sponsored by University of Cincinnati. Started Sep 2010; status: completed.

02

Drugs

mycophenolic acid
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT01336296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01336296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call